NCT02454868View on ClinicalTrials.gov

Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Underdosing of Unspecified General Anesthetics
Interventions
DRUG

Remifentanil

Remifentanil for intubation without neuromuscular blockade

All Listed Sponsors
collaborator

University of Brasilia

OTHER

lead

Brasilia University Hospital

OTHER

NCT02454868 - Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade | Biotech Hunter | Biotech Hunter